Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Here are five questions answered about the FDA's decision to halt compounded versions of GLP-1 drugs. The FDA says state-licensed compounding pharmacies must immediately stop making most compound ...

THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...

Opens in a new tab or window Use of GLP-1 receptor agonists for obesity was tied to a reduced risk of glaucoma versus other weight-loss drugs. The findings were in line with those of a previous ...

These drugs function by mimicking the natural hormone GLP-1, which is released by intestinal L cells in response to food intake. Their primary role in metabolic regulation involves stimulating ...